Related Experiment Video
Updated: Jul 7, 2025
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Hepatorenal Syndrome-Novel Insights into Diagnostics and Treatment
Krzysztof Badura1, Weronika Frąk1, Joanna Hajdys1
1Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland.
Insights
Hepatorenal syndrome (HRS), a kidney issue in cirrhosis patients, is increasingly understood through new biomarkers and mechanisms. Research advances management strategies, including novel therapies, to improve patient outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Nephrology
- Critical Care Medicine
Background:
- Hepatorenal syndrome (HRS) is a severe complication of cirrhosis, characterized by renal impairment.
- It is a leading cause of acute kidney injury, posing a significant public health challenge.
- Portal hypertension is the primary underlying cause of HRS.
Purpose of the Study:
- To review the pathophysiological mechanisms contributing to HRS.
- To summarize current and emerging management strategies for HRS.
- To highlight recent advancements in understanding and diagnosing HRS.
Main Methods:
- Literature review of pathophysiological mechanisms.
- Analysis of diagnostic advancements, including biomarkers.
- Summary of therapeutic interventions and novel treatments.
Main Results:
- Key pathophysiological pathways identified include circulatory dysfunction, bacterial infection, inflammation, and impaired renal autoregulation.
- New biomarkers for renal injury are aiding in HRS diagnosis.
- Current management involves vasoconstrictive drugs, renal replacement therapy, and liver transplantation.
Conclusions:
- Understanding the complex pathophysiology of HRS is crucial for developing effective prevention and treatment strategies.
- Ongoing research into novel therapies holds promise for improving outcomes in patients with HRS.
- Integrated approaches combining medical management and transplantation are essential.
Abstract:
Hepatorenal syndrome (HRS) is a disorder associated with cirrhosis and renal impairment, with portal hypertension as its major underlying cause. Moreover, HRS is the third most common cause of acute kidney injury, thus creating a major public health concern. This review summarizes the available information on the pathophysiological implications of HRS. We discuss pathogenesis associated with HRS. Mechanisms such as dysfunction of the circulatory system, bacterial infection, inflammation, impaired renal autoregulation, circulatory, and others, which have been identified as critical pathways for development of HRS, have become easier to diagnose in recent years. Additionally, relatively recently, renal dysfunction biomarkers have been found indicating renal injury, which are involved in the pathophysiology of HRS. This review also summarizes the available information on the management of HRS, focusing on vasoconstrictive drugs, renal replacement therapy, and liver transplant together with currently being investigated novel therapies. Analyzing new discoveries for the underlying causes of this condition assists the general research to improve understanding of the mechanism of pathophysiology and thus prevention of HRS.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System